Skip to main content

Advanced Medical Solutions Value Stock - Dividend - Research Selection

Advanced Medical Solutions Group

ISIN: GB0004536594, WKN: 905598

Market price date: 11.09.2020
Market price: 2,42 GBP




Advanced Medical Solutions Group Fundamental data and company key figures of the share

Annual reports in GBP
Key figures 12-05-2020
Cash flow
Net operating cash flow 21.699.000
Capital Expenditures -5.854.000
Free cash flow 15.845.000
Balance sheet
Total Equity 191.235.000
Liabilities & Shareholders equity 226.982.000
Income statement
Net income 18.919.000
Eps (diluted) 0,090
Diluted shares outstanding 210.211.000
Net sales/revenue 102.368.000

Fundamental ratios calculated on: 11-09-2020

Ratios
Key figures 11-09-2020
Cash flow
P/C 22,09
   
P/FC 30,25
Balance sheet
ROI8,34
ROE84,25
Income statement
P/E25,33
Div. Yield0,88%
P/B2,51
P/S4,68


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolAMS.LSE
Market Capitalization669.708.544,00 USD
CountryUnited Kingdom
IndicesNO INDEX
SectorsHealth service
Raw Data SourceIFRS in Millionen GBP
Stock Split2002-04-02,10000.000000/10104.000000; 1999-12-13,10.000000/11.000000; 1998-11-06,10000.000000/10245.000000; 1997-06-23,10000.000000/10080.000000; 1996-02-15,10000.000000/11634.000000
Internetwww.admedsol.com


Description of the company

Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets worldwide. It operates in two segments, Branded and OEM. The Branded segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand; wound care products under the ActivHeal; sutures and collagen based products for the surgical and dental markets under the RESORBA; and laparoscopic device under the LiquiBand Fix8 brands. The OEM segment provides wound care platform technologies, which include alginates, foams, films, fibres, collagens, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products and bulk materials to business-to-business partners and third party convertors. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.admedsol.com